Wright Don - 17 Jun 2025 Form 4 Insider Report for International Stem Cell CORP (ISCO)

Role
Director
Signature
/s/ Russell Kern, as Attorney-in-Fact
Issuer symbol
ISCO
Transactions as of
17 Jun 2025
Net transactions value
$0
Form type
4
Filing time
20 Jun 2025, 08:21:17 UTC
Previous filing
13 Jun 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Don Wright Director C/O INTERNATIONAL STEM CELL CORP., 9745 BUSINESSPARK AVENUE, SAN DIEGO /s/ Russell Kern, as Attorney-in-Fact 19 Jun 2025 0001405212

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISCO Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 17 Jun 2025 Common Stock 30,000 $0.1300 Direct F1
transaction ISCO Stock Option (Right to Buy) Award $0 +532,786 $0.000000 532,786 17 Jun 2025 Common Stock 532,786 $0.1300 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying such option shall vest on the earlier of (a) June 17, 2026, or (b) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant.
F2 The shares underlying such option shall vest in equal quarterly increments through June 17, 2026, with the first increment vesting on September 17, 2025.